HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesScenario AnalysisRegulatoryStrategyInsightsPricing

Workspace

Workspace

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance83% confidence

Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention

Source: FDA

Why This Matters

Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction.

Regulatory Analysis

Supporting Context

Therapeutic area
Pain Management · Anesthesia
Sub-indication
Pain

Related signal: Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction

Source

View source document

Related Signal

Open signal — Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction
PrivacyTermsRefund PolicyDisclaimer

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.